lobbying_activities: 2420586
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2420586 | 58c7edb3-ff7e-43d2-bf66-477a55476564 | Q1 | 4C COMMUNICATIONS, INC. | 323717 | HEALTHCARE LEADERSHIP COUNCIL | 2020 | first_quarter | PHA | Discussion on pharmaceutical drug pricing; cost of pharmaceutical drugs in the Medicare Part D program | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2020-04-01T14:45:17.390000-04:00 |